Development or worsening of sarcoidosis associated with IL-17 blockade for psoriasis

N Hornick¹, A Wang¹, Y Lim¹, J Gehlhausen¹, J Siegel¹, J Wang¹, F Foss^{1

2}, I Lim¹, A Zubek¹, L Milstone¹, A Galan^{1

3}, B King¹, W Damsky¹

Affiliations

¹ Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.
² Department of Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
³ Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

N Hornick et al. J Eur Acad Dermatol Venereol. 2020 Oct.

. 2020 Oct;34(10):e583-e585.

doi: 10.1111/jdv.16451. Epub 2020 May 19.

N Hornick¹, A Wang¹, Y Lim¹, J Gehlhausen¹, J Siegel¹, J Wang¹, F Foss^{1

2}, I Lim¹, A Zubek¹, L Milstone¹, A Galan^{1

3}, B King¹, W Damsky¹

¹ Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.
² Department of Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
³ Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

No abstract available

References

1. HusainZ, ReddyBY, SchwartzRA. DRESS syndrome. J Am Acad Dermatol2013; 68: 693.e1.e14; quiz 706-708.
1. NyckowskiT, CeilleyR, WilsonJ. Sarcoidosis developing during secukinumab therapy: case report. J Cutan Med2017; 1: 5.
1. SambhariaM, MaggeTRamakrishnaS. Worsening of pulmonary sarcoidosis induced by ixekizumab: a rare paradox. Chest2018; 154: 898A.
1. BonomoL, GhoneimS, LevittJ. A case of granuloma annulare associated with secukinumab use. Case Rep Dermatol Med2017; 2017: 5918708.
1. ClarkML, TobinCA, SuttonA, MissallTA. Granuloma annulare in the setting of secukinumab. Case Rep Dermatol Med2018; 2018: 5175319.